This is a Validated Antibody Database (VAD) review about human syndecan, based on 97 published articles (read how Labome selects the articles), using syndecan antibody in all methods. It is aimed to help Labome visitors find the most suited syndecan antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
syndecan synonym: CD138; SDC; SYND1; syndecan

Abcam
mouse monoclonal (B-A38)
  • immunohistochemistry; human; 1:100; loading ...; fig 2c
Abcam syndecan antibody (Abcam, ab34164) was used in immunohistochemistry on human samples at 1:100 (fig 2c). Bioengineering (Basel) (2022) ncbi
mouse monoclonal (B-A38)
  • flow cytometry; rat; loading ...; fig 8d
Abcam syndecan antibody (Abcam, B-A38) was used in flow cytometry on rat samples (fig 8d). PLoS ONE (2022) ncbi
domestic rabbit monoclonal (EPR6454)
  • immunohistochemistry; human; 1:500; fig 1c
Abcam syndecan antibody (Abcam, ab128936) was used in immunohistochemistry on human samples at 1:500 (fig 1c). elife (2022) ncbi
domestic rabbit monoclonal (EPR6454)
  • immunohistochemistry - paraffin section; human; 1:400; fig 1a, 1b
Abcam syndecan antibody (Abcam, ab128936) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 1a, 1b). Front Oncol (2021) ncbi
mouse monoclonal (B-A38)
  • immunohistochemistry; human; 1:100; loading ...; fig 2a
Abcam syndecan antibody (Abcam, ab34164) was used in immunohistochemistry on human samples at 1:100 (fig 2a). Sci Rep (2021) ncbi
mouse monoclonal (B-A38)
  • western blot; mouse; fig 4a
Abcam syndecan antibody (Abcam, AB-34164) was used in western blot on mouse samples (fig 4a). Alzheimers Res Ther (2021) ncbi
mouse monoclonal (B-A38)
  • western blot; mouse; loading ...; fig 2a
Abcam syndecan antibody (Abcam, ab34164) was used in western blot on mouse samples (fig 2a). Br J Pharmacol (2020) ncbi
domestic rabbit monoclonal (EPR6454)
  • immunohistochemistry - paraffin section; mouse; 1:2000; loading ...; fig 6a
Abcam syndecan antibody (Abcam, ab128936) was used in immunohistochemistry - paraffin section on mouse samples at 1:2000 (fig 6a). Int J Oncol (2018) ncbi
domestic rabbit monoclonal (EPR6454)
  • western blot; rat; 1:2000; loading ...; fig 6a
Abcam syndecan antibody (Abcam, ab128936) was used in western blot on rat samples at 1:2000 (fig 6a). Mol Cell Biochem (2019) ncbi
mouse monoclonal (B-A38)
  • immunohistochemistry; human; loading ...; fig 5f
In order to investigate the role of ILF2 in RNA splicing and DNA damage response in multiple myeloma, Abcam syndecan antibody (Abcam, ab34164) was used in immunohistochemistry on human samples (fig 5f). Cancer Cell (2017) ncbi
mouse monoclonal (B-A38)
  • proximity ligation assay; human; 1:50; fig 7
  • immunocytochemistry; human; 1:50; fig 6
In order to characterize the interaction between VAR2CSA and chondroitin sulfate proteoglycans, Abcam syndecan antibody (abcam, ab34164) was used in proximity ligation assay on human samples at 1:50 (fig 7) and in immunocytochemistry on human samples at 1:50 (fig 6). PLoS Pathog (2016) ncbi
mouse monoclonal (B-A38)
  • flow cytometry; human; loading ...; fig 2a
In order to characterize B cells and antibody repertoires from injection drug users, Abcam syndecan antibody (Abcam, B-A38) was used in flow cytometry on human samples (fig 2a). PLoS ONE (2016) ncbi
mouse monoclonal (B-A38)
  • flow cytometry; mouse; fig s3
  • immunoprecipitation; human; fig 4
In order to study stretch-activated channels to set cytosolic calcium levels controlled by transmembrane proteoglycans, Abcam syndecan antibody (Abcam, B-A38) was used in flow cytometry on mouse samples (fig s3) and in immunoprecipitation on human samples (fig 4). J Cell Biol (2015) ncbi
domestic rabbit monoclonal (EPR6454)
  • western blot; human; fig 1
Abcam syndecan antibody (Epitomics, 5608) was used in western blot on human samples (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (B-A38)
  • immunohistochemistry - paraffin section; mouse
In order to study the role of heparan sulfate in corneal epithelial homeostasis and wound healing, Abcam syndecan antibody (Abcam, ab34164) was used in immunohistochemistry - paraffin section on mouse samples . Invest Ophthalmol Vis Sci (2015) ncbi
mouse monoclonal (B-A38)
  • flow cytometry; human; 1:50
  • western blot; human
In order to study the roll of cell surface heparan sulfate proteoglycans in relation to cell adhesion, Abcam syndecan antibody (Abcam, B-A38) was used in flow cytometry on human samples at 1:50 and in western blot on human samples . Mol Cancer (2015) ncbi
mouse monoclonal (B-A38)
  • immunohistochemistry - paraffin section; human; 1:400
In order to validate the expression of a urine-based bladder cancer associated diagnostic signature, Abcam syndecan antibody (Abcam, ab34164) was used in immunohistochemistry - paraffin section on human samples at 1:400. Diagn Pathol (2014) ncbi
mouse monoclonal (B-A38)
  • immunohistochemistry - paraffin section; mouse
In order to study the role of heparan sulfate in hair follicle and sebaceous gland morphogenesis and homeostasis, Abcam syndecan antibody (Abcam, ab34164) was used in immunohistochemistry - paraffin section on mouse samples . J Biol Chem (2014) ncbi
mouse monoclonal (B-A38)
  • immunocytochemistry; human
In order to understand the effect of protein kinase C phosphorylation on cell susceptibility to baculovirus transduction and echovirus infection, Abcam syndecan antibody (Abcam, B-A38) was used in immunocytochemistry on human samples . J Virol (2013) ncbi
BioLegend
mouse monoclonal (DL-101)
  • flow cytometry; human; 1:100; loading ...; fig s3b
  • immunoprecipitation; human; 5 ug/ml; loading ...; fig 2b
  • immunocytochemistry; human; 1:100; loading ...; fig s3a
BioLegend syndecan antibody (BioLegend, 352307) was used in flow cytometry on human samples at 1:100 (fig s3b), in immunoprecipitation on human samples at 5 ug/ml (fig 2b) and in immunocytochemistry on human samples at 1:100 (fig s3a). iScience (2021) ncbi
mouse monoclonal (MI15)
  • immunohistochemistry; mouse; loading ...; fig 5b
BioLegend syndecan antibody (Biolegend, MI15) was used in immunohistochemistry on mouse samples (fig 5b). Front Immunol (2021) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; loading ...; fig 1c
BioLegend syndecan antibody (BioLegend, 356504) was used in flow cytometry on human samples (fig 1c). Immunity (2021) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; loading ...; fig 4b
BioLegend syndecan antibody (Biolegend, MI15) was used in flow cytometry on human samples (fig 4b). Cell Death Dis (2020) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; 1:200; loading ...; fig 4a
BioLegend syndecan antibody (BioLegend, 356514) was used in flow cytometry on human samples at 1:200 (fig 4a). elife (2020) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; 1:25; loading ...
BioLegend syndecan antibody (Biolegend, 356520) was used in flow cytometry on human samples at 1:25. bioRxiv (2020) ncbi
mouse monoclonal (MI15)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 1h
BioLegend syndecan antibody (BioLegend, 356502) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1h). Front Immunol (2019) ncbi
mouse monoclonal (DL-101)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig e5b
BioLegend syndecan antibody (Biolegend, DL-101) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig e5b). Nature (2019) ncbi
mouse monoclonal (DL-101)
  • flow cytometry; human; loading ...; fig e10c
BioLegend syndecan antibody (Biolegend, 352308) was used in flow cytometry on human samples (fig e10c). Nature (2019) ncbi
mouse monoclonal (DL-101)
  • flow cytometry; human; loading ...; fig s5
BioLegend syndecan antibody (Biolegend, 352307) was used in flow cytometry on human samples (fig s5). J Clin Invest (2018) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; fig 1a
BioLegend syndecan antibody (BioLegend, MI15) was used in flow cytometry on human samples (fig 1a). Blood (2018) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; loading ...; fig 5a
BioLegend syndecan antibody (BioLegend, MI15) was used in flow cytometry on human samples (fig 5a). J Virol (2017) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human
In order to characterize activated T cells in joint tissue from patients with rheumatoid arthritis, BioLegend syndecan antibody (biolegend, MI15) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (DL-101)
  • flow cytometry; human; fig 5
In order to determine the differential regulation of the inflammatory phenotype of brain microvascular endothelial cells by pro-inflammatory TNFalpha and IL-1beta, BioLegend syndecan antibody (Biolegend, 352307) was used in flow cytometry on human samples (fig 5). J Neuroinflammation (2015) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; fig 6
BioLegend syndecan antibody (Biolegend, MI15) was used in flow cytometry on human samples (fig 6). Am J Hum Genet (2015) ncbi
mouse monoclonal (DL-101)
BioLegend syndecan antibody (BioLegend, DL-101) was used . Biomed Res Int (2014) ncbi
Invitrogen
mouse monoclonal (MI15)
  • immunohistochemistry - paraffin section; human; 1:50; fig 4a
Invitrogen syndecan antibody (Thermo Fisher, MA5-12400) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 4a). Acta Neuropathol Commun (2020) ncbi
mouse monoclonal (DL-101)
  • flow cytometry; human; 1:50; fig 2a
Invitrogen syndecan antibody (eBioscience/Thermo, 17-1389-42) was used in flow cytometry on human samples at 1:50 (fig 2a). Stem Cells (2019) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:250; loading ...; fig 4a
Invitrogen syndecan antibody (Life Technologies, 36-2900) was used in western blot on mouse samples at 1:250 (fig 4a). Sci Adv (2019) ncbi
mouse monoclonal (DL-101)
  • flow cytometry; human; loading ...; fig 8a
Invitrogen syndecan antibody (eBioscience, 12-1389-42) was used in flow cytometry on human samples (fig 8a). Nat Commun (2018) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig s5l
In order to identify an astrocyte subtype induced by activated microglia, Invitrogen syndecan antibody (Invitrogen, 36-2900) was used in western blot on mouse samples at 1:1000 (fig s5l). Nature (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:25; loading ...; fig 1
In order to assess if low-intensity vibration protects bone and marrow during myeloma progression, Invitrogen syndecan antibody (Thermo Scientific, PA5-32305) was used in immunohistochemistry - paraffin section on human samples at 1:25 (fig 1). Bone (2016) ncbi
mouse monoclonal (DL-101)
  • flow cytometry; human; 1:100; fig 7
Invitrogen syndecan antibody (eBioscience, 12-1389) was used in flow cytometry on human samples at 1:100 (fig 7). Haematologica (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:500; fig 3
In order to determine how Bmp signaling in colonic mesenchyme regulates stromal microenvironment and protects from initiation of polyposis, Invitrogen syndecan antibody (Zymed, 36-2900) was used in western blot on mouse samples at 1:500 (fig 3). Int J Cancer (2016) ncbi
domestic rabbit monoclonal (SP152)
  • immunohistochemistry - paraffin section; human; 1:100; fig 5
In order to characterize ovarian serous and clear cell carcinomas for CD138 immunohistochemical expression and mammary serine protease inhibitor, Invitrogen syndecan antibody (Lab Vision, MA5-16331) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 5). Tumour Biol (2016) ncbi
mouse monoclonal (DL-101)
  • flow cytometry; human; 1:40
Invitrogen syndecan antibody (eBioscience, DL-101) was used in flow cytometry on human samples at 1:40. Nat Commun (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (A-6)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 1a
Santa Cruz Biotechnology syndecan antibody (Santa Cruz, sc-390791) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1a). Int J Mol Sci (2022) ncbi
mouse monoclonal (DL-101)
  • proximity ligation assay; human; 1:200; loading ...; fig 6b
  • immunoprecipitation; human; loading ...; fig 6a
  • immunocytochemistry; human; fig 1
Santa Cruz Biotechnology syndecan antibody (Santa Cruz, DL-101) was used in proximity ligation assay on human samples at 1:200 (fig 6b), in immunoprecipitation on human samples (fig 6a) and in immunocytochemistry on human samples (fig 1). Cell Microbiol (2017) ncbi
mouse monoclonal (DL-101)
  • western blot; human; loading ...; fig 5
Santa Cruz Biotechnology syndecan antibody (Santa Cruz, sc-12765) was used in western blot on human samples (fig 5). J Virol (2017) ncbi
mouse monoclonal (A-6)
  • western blot; human; 1:1000; loading ...; fig 6d
Santa Cruz Biotechnology syndecan antibody (Santa Cruz, sc-390791) was used in western blot on human samples at 1:1000 (fig 6d). Oncotarget (2016) ncbi
mouse monoclonal (DL-101)
  • flow cytometry; human; loading ...; fig 5
In order to demonstrate that proline/arginine-rich end leucine-rich repeat protein mediates cell adhesion by binding to cell-surface glycosaminoglycans, Santa Cruz Biotechnology syndecan antibody (Santa Cruz, sc-12765) was used in flow cytometry on human samples (fig 5). Biochem J (2016) ncbi
mouse monoclonal (DL-101)
  • flow cytometry; human
  • western blot; human
Santa Cruz Biotechnology syndecan antibody (Santa Cruz Biotechnology, DL-101) was used in flow cytometry on human samples and in western blot on human samples . Cell Mol Life Sci (2015) ncbi
mouse monoclonal (DL-101)
  • immunohistochemistry - paraffin section; pigs ; 1:25
Santa Cruz Biotechnology syndecan antibody (Santa Cruz, DL-101) was used in immunohistochemistry - paraffin section on pigs samples at 1:25. Singapore Med J (2014) ncbi
Bio-Rad
mouse monoclonal (B-A38)
  • immunohistochemistry - frozen section; human; loading ...; fig 1a
Bio-Rad syndecan antibody (Bio-Rad, MCA2459GA) was used in immunohistochemistry - frozen section on human samples (fig 1a). Blood (2021) ncbi
mouse monoclonal (B-A38)
  • immunohistochemistry; human; 1.0 ug/ml; loading ...; fig 4
Bio-Rad syndecan antibody (AbD Serotec, MCA2459GA) was used in immunohistochemistry on human samples at 1.0 ug/ml (fig 4). Part Fibre Toxicol (2016) ncbi
mouse monoclonal (B-A38)
  • immunohistochemistry; human; 1:200
Bio-Rad syndecan antibody (Serotec, MCA2459GA) was used in immunohistochemistry on human samples at 1:200. PLoS ONE (2014) ncbi
mouse monoclonal (B-A38)
  • flow cytometry; human
Bio-Rad syndecan antibody (AbD Serotec, B-A38) was used in flow cytometry on human samples . Biomed Res Int (2014) ncbi
mouse monoclonal (B-A38)
  • flow cytometry; human; 1:10
Bio-Rad syndecan antibody (Serotec, MCA2459A647T) was used in flow cytometry on human samples at 1:10. Anal Chem (2013) ncbi
Miltenyi Biotec
mouse monoclonal (44F9)
  • immunohistochemistry; rhesus macaque; 1:1000
Miltenyi Biotec syndecan antibody (Miltenyi Biotec, 130-119-927) was used in immunohistochemistry on rhesus macaque samples at 1:1000. BMC Biol (2021) ncbi
Dako
mouse monoclonal (MI15)
  • immunohistochemistry; human; 1:500; fig s7a
Dako syndecan antibody (Dako, MI15, M7228) was used in immunohistochemistry on human samples at 1:500 (fig s7a). Nature (2021) ncbi
mouse monoclonal (MI15)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig s2
Dako syndecan antibody (Dako, MI15) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig s2). Exp Eye Res (2020) ncbi
mouse monoclonal (MI15)
  • immunohistochemistry - paraffin section; human; 1:100; fig 6d
In order to report the post-transplant lymphoproliferative disorders present in exfoliative cytology specimens, Dako syndecan antibody (Dako, MI15) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 6d). Cancer Cytopathol (2016) ncbi
mouse monoclonal (MI15)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2
In order to evaluate the promotion of B cell activation and CXCR4 downregulation by CD161 and LLT1 expression in human germinal centers, Dako syndecan antibody (Dako, MI15) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). J Immunol (2016) ncbi
mouse monoclonal (MI15)
  • immunohistochemistry; human; 1:100; tbl 1
Dako syndecan antibody (Dako, MI15) was used in immunohistochemistry on human samples at 1:100 (tbl 1). Oral Surg Oral Med Oral Pathol Oral Radiol (2016) ncbi
mouse monoclonal (MI15)
  • immunohistochemistry; human; 1:100
Dako syndecan antibody (Dako, MI15) was used in immunohistochemistry on human samples at 1:100. Hum Pathol (2015) ncbi
mouse monoclonal (MI15)
  • immunohistochemistry; human
Dako syndecan antibody (Dako, clone MI15) was used in immunohistochemistry on human samples . Brain Tumor Pathol (2015) ncbi
mouse monoclonal (MI15)
  • immunohistochemistry; human; 1:25; fig 1,2,3,4,5,6,7
In order to show that Che-1 inhibits mTOR activity in response to stress conditions, Dako syndecan antibody (Dako, M7228) was used in immunohistochemistry on human samples at 1:25 (fig 1,2,3,4,5,6,7). EMBO J (2015) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; fig 2
Dako syndecan antibody (Dako, MI15) was used in flow cytometry on human samples (fig 2). Blood (2015) ncbi
mouse monoclonal (MI15)
  • immunohistochemistry; human; 1:50
Dako syndecan antibody (Dakocytomation, MI15) was used in immunohistochemistry on human samples at 1:50. Appl Immunohistochem Mol Morphol (2015) ncbi
mouse monoclonal (MI15)
  • immunocytochemistry; human; 1:250
  • ELISA; human; 1:250
Dako syndecan antibody (Dako, MI15) was used in immunocytochemistry on human samples at 1:250 and in ELISA on human samples at 1:250. J Immunol (2014) ncbi
mouse monoclonal (MI15)
  • immunohistochemistry - paraffin section; human; 1:100
Dako syndecan antibody (Dako, MI15) was used in immunohistochemistry - paraffin section on human samples at 1:100. Ann Hematol (2014) ncbi
mouse monoclonal (MI15)
  • immunohistochemistry - paraffin section; human; 1:50
Dako syndecan antibody (Dako A/S, MI15) was used in immunohistochemistry - paraffin section on human samples at 1:50. Clin Exp Allergy (2014) ncbi
mouse monoclonal (MI15)
  • immunohistochemistry - paraffin section; human; 1:100
Dako syndecan antibody (DAKO, MI15) was used in immunohistochemistry - paraffin section on human samples at 1:100. Am J Clin Pathol (2013) ncbi
mouse monoclonal (MI15)
  • immunohistochemistry - paraffin section; human
In order to investigate the clinical and pathological features in a girl with common variable immunodeficiency, Dako syndecan antibody (Dako, MI15) was used in immunohistochemistry - paraffin section on human samples . Int J Surg Pathol (2014) ncbi
mouse monoclonal (MI15)
  • immunohistochemistry - paraffin section; human; 1:50
In order to investigate the mechanism for the non-responsiveness to prostaglandin priming in cervix of postterm women, Dako syndecan antibody (DakoCytomation, M7228) was used in immunohistochemistry - paraffin section on human samples at 1:50. Reprod Biol Endocrinol (2008) ncbi
Beckman Coulter
mouse monoclonal (B-A38)
  • flow cytometry; human; loading ...; fig s4a
Beckman Coulter syndecan antibody (Beckman Coulter, B-A38) was used in flow cytometry on human samples (fig s4a). Nat Commun (2020) ncbi
mouse monoclonal (B-A38)
  • flow cytometry; human
In order to evaluate the promotion of B cell activation and CXCR4 downregulation by CD161 and LLT1 expression in human germinal centers, Beckman Coulter syndecan antibody (Beckman Coulter, B-A38) was used in flow cytometry on human samples . J Immunol (2016) ncbi
mouse monoclonal (B-A38)
  • flow cytometry; human; tbl 4
In order to discuss how to diagnosis hematolymphoid neoplasms using flow cytometry, Beckman Coulter syndecan antibody (Beckman Coulter, B-A38) was used in flow cytometry on human samples (tbl 4). Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (B-A38)
  • flow cytometry; human
In order to test if macrophages contribute to the effect of daratumumab treatment, Beckman Coulter syndecan antibody (Beckman, A87787) was used in flow cytometry on human samples . MAbs (2015) ncbi
mouse monoclonal (B-A38)
  • flow cytometry; human; fig 3
Beckman Coulter syndecan antibody (Beckman Coulter, B-A38) was used in flow cytometry on human samples (fig 3). Blood (2015) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D4Y7H)
  • western blot; human; 1:1000; loading ...; fig 6a
Cell Signaling Technology syndecan antibody (Cell Signaling, 12922S) was used in western blot on human samples at 1:1000 (fig 6a). Oncotarget (2016) ncbi
Agilent Technologies
monoclonal (MI15)
  • immunohistochemistry - paraffin section; human; loading ...; fig 2
Agilent Technologies syndecan antibody (Agilent, M722801) was used in immunohistochemistry - paraffin section on human samples (fig 2). J Clin Invest (2019) ncbi
BD Biosciences
mouse monoclonal (MI15)
  • flow cytometry; human; loading ...; fig s6g
BD Biosciences syndecan antibody (BD Biosciences, 552026) was used in flow cytometry on human samples (fig s6g). Nat Commun (2022) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences syndecan antibody (BD Biosciences, 552026) was used in flow cytometry on human samples (fig 3a). Front Oncol (2021) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; loading ...
BD Biosciences syndecan antibody (Biosciences, 347193BD) was used in flow cytometry on human samples . J Clin Invest (2020) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; loading ...; fig s10b
BD Biosciences syndecan antibody (BD Biosciences, 552026) was used in flow cytometry on human samples (fig s10b). Nat Commun (2019) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences syndecan antibody (BD Biosciences, MI15) was used in flow cytometry on human samples (fig 1a). Blood Cancer J (2019) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences syndecan antibody (BD Bioscience, MI15) was used in flow cytometry on human samples (fig s1). Haematologica (2017) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BD Biosciences syndecan antibody (BD Biosciences, MI15) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; loading ...; fig s12a
BD Biosciences syndecan antibody (BD Biosciences, MI15) was used in flow cytometry on human samples (fig s12a). J Clin Invest (2016) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; loading ...; fig 4c
BD Biosciences syndecan antibody (BD Biosciences, 347206) was used in flow cytometry on human samples (fig 4c). J Clin Invest (2016) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; loading ...
In order to utilize humanized major histocompatibility class I- and class II-deficient NOG mice to assess the antitumor effect of an anti-programmed death-1 antibody, BD Biosciences syndecan antibody (BD Pharmingen, MI15) was used in flow cytometry on human samples . Clin Cancer Res (2017) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; loading ...
BD Biosciences syndecan antibody (BD Biosciences, 341097) was used in flow cytometry on human samples . Oncol Lett (2016) ncbi
mouse monoclonal (MI15)
  • flow cytometry; African green monkey; loading ...; fig s1
In order to discuss the use of flow cytometry to examine common marmosets, BD Biosciences syndecan antibody (BD, MI15) was used in flow cytometry on African green monkey samples (fig s1). J Med Primatol (2016) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; fig 2
BD Biosciences syndecan antibody (BD, MI15) was used in flow cytometry on human samples (fig 2). JCI Insight (2016) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences syndecan antibody (BD, 552026) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; loading ...; tbl 1
In order to compare the use of CD229, CD54, and CD319 expression for the identification of normal and aberrant plasma cells, BD Biosciences syndecan antibody (BD, MI15) was used in flow cytometry on human samples (tbl 1). Cytometry B Clin Cytom (2016) ncbi
mouse monoclonal (MI15)
  • immunocytochemistry; human; 1:200; fig 6c
In order to analyze proliferation and homing of multiple myeloma cells promoted by the cyclophilin A-CD147 complex, BD Biosciences syndecan antibody (Becton Dickinson, MI15) was used in immunocytochemistry on human samples at 1:200 (fig 6c). Nat Med (2015) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; tbl 4
In order to discuss how to diagnosis hematolymphoid neoplasms using flow cytometry, BD Biosciences syndecan antibody (BD Bioscience, MI15) was used in flow cytometry on human samples (tbl 4). Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human
BD Biosciences syndecan antibody (Becton Dickinson, MI-15) was used in flow cytometry on human samples . Biomed Res Int (2014) ncbi
mouse monoclonal (MI15)
  • flow cytometry; human; loading ...; fig 2a
In order to screen for and assess myeloma plasma cell markers, BD Biosciences syndecan antibody (BD Biosciences, MI15) was used in flow cytometry on human samples (fig 2a). Blood (2014) ncbi
Leica Biosystems
monoclonal (MI15)
  • immunohistochemistry - paraffin section; human; tbl 1
Leica Biosystems syndecan antibody (Novocastra, MI15) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Rom J Morphol Embryol (2016) ncbi
mouse monoclonal (5F7)
  • immunohistochemistry - paraffin section; human; 1:50
Leica Biosystems syndecan antibody (Novocastra, 5F7) was used in immunohistochemistry - paraffin section on human samples at 1:50. J Eur Acad Dermatol Venereol (2015) ncbi
Articles Reviewed
  1. Duplancic R, Roguljić M, Bozić D, Kero D. Heparan Sulfate Glycosaminoglycan Is Predicted to Stabilize Inflammatory Infiltrate Formation and RANKL/OPG Ratio in Severe Periodontitis in Humans. Bioengineering (Basel). 2022;9: pubmed publisher
  2. Bath N, Verhoven B, Wilson N, Zeng W, Zhong W, Coons L, et al. APRIL/BLyS deficient rats prevent donor specific antibody (DSA) production and cell proliferation in rodent kidney transplant model. PLoS ONE. 2022;17:e0275564 pubmed publisher
  3. Yang L, Semmes E, Ovies C, Megli C, Permar S, Gilner J, et al. Innate immune signaling in trophoblast and decidua organoids defines differential antiviral defenses at the maternal-fetal interface. elife. 2022;11: pubmed publisher
  4. Ferguson I, Pati xf1 o Escobar B, Tuomivaara S, Lin Y, Nix M, Leung K, et al. The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance. Nat Commun. 2022;13:4121 pubmed publisher
  5. Koliakou E, Eleni M, Koumentakou I, Bikiaris N, Konstantinidou P, Rousselle P, et al. Altered Distribution and Expression of Syndecan-1 and -4 as an Additional Hallmark in Psoriasis. Int J Mol Sci. 2022;23: pubmed publisher
  6. Wellemans V, Benhassou H, Fuselier E, Bellesort F, Dury S, Lebargy F, et al. Role of CCR3 in respiratory syncytial virus infection of airway epithelial cells. iScience. 2021;24:103433 pubmed publisher
  7. Xu J, Yu N, Zhao P, Wang F, Huang J, Cui Y, et al. Intratumor Heterogeneity of MIF Expression Correlates With Extramedullary Involvement of Multiple Myeloma. Front Oncol. 2021;11:694331 pubmed publisher
  8. Yue X, Petersen F, Shu Y, Kasper B, Magatsin J, Ahmadi M, et al. Transfer of PBMC From SSc Patients Induces Autoantibodies and Systemic Inflammation in Rag2-/-/IL2rg-/- Mice. Front Immunol. 2021;12:677970 pubmed publisher
  9. Rosenkrantz J, Gaffney J, Roberts V, Carbone L, CHAVEZ S. Transcriptomic analysis of primate placentas and novel rhesus trophoblast cell lines informs investigations of human placentation. BMC Biol. 2021;19:127 pubmed publisher
  10. Duplancic R, Kero D. Novel approach for quantification of multiple immunofluorescent signals using histograms and 2D plot profiling of whole-section panoramic images. Sci Rep. 2021;11:8619 pubmed publisher
  11. Szabo P, Dogra P, Gray J, Wells S, Connors T, Weisberg S, et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity. 2021;54:797-814.e6 pubmed publisher
  12. Sewastianik T, Straubhaar J, Zhao J, Samur M, Adler K, Tanton H, et al. miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms. Blood. 2021;137:1905-1919 pubmed publisher
  13. Biswas S, Mandal G, Payne K, Anadon C, Gatenbee C, Chaurio R, et al. IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature. 2021;591:464-470 pubmed publisher
  14. Pons V, Lévesque P, Plante M, Rivest S. Conditional genetic deletion of CSF1 receptor in microglia ameliorates the physiopathology of Alzheimer's disease. Alzheimers Res Ther. 2021;13:8 pubmed publisher
  15. Luo B, Zhan Y, Luo M, Dong H, Liu J, Lin Y, et al. Engineering of α-PD-1 antibody-expressing long-lived plasma cells by CRISPR/Cas9-mediated targeted gene integration. Cell Death Dis. 2020;11:973 pubmed publisher
  16. Tan E, Hopkins R, Lim C, Jamuar S, Ong C, Thoon K, et al. Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency. J Clin Invest. 2020;130:5817-5832 pubmed publisher
  17. Danzer H, Glaesner J, Baerenwaldt A, Reitinger C, Lux A, Heger L, et al. Human Fcγ-receptor IIb modulates pathogen-specific versus self-reactive antibody responses in lyme arthritis. elife. 2020;9: pubmed publisher
  18. Mathew D, Giles J, Baxter A, Greenplate A, Wu J, Alanio C, et al. Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions. bioRxiv. 2020;: pubmed publisher
  19. Suzuki K, Okada H, Takemura G, Takada C, Tomita H, Yano H, et al. Recombinant thrombomodulin protects against LPS-induced acute respiratory distress syndrome via preservation of pulmonary endothelial glycocalyx. Br J Pharmacol. 2020;177:4021-4033 pubmed publisher
  20. Rodríguez Lorenzo S, Konings J, van der Pol S, Kamermans A, Amor S, van Horssen J, et al. Inflammation of the choroid plexus in progressive multiple sclerosis: accumulation of granulocytes and T cells. Acta Neuropathol Commun. 2020;8:9 pubmed publisher
  21. Bell L, Lenhart A, Rosenwald A, Monoranu C, Berberich Siebelt F. Lymphoid Aggregates in the CNS of Progressive Multiple Sclerosis Patients Lack Regulatory T Cells. Front Immunol. 2019;10:3090 pubmed publisher
  22. Schafflick D, Xu C, Hartlehnert M, Cole M, Schulte Mecklenbeck A, Lautwein T, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11:247 pubmed publisher
  23. Epps S, Coplin N, Luthert P, Dick A, Coupland S, Nicholson L. Features of ectopic lymphoid-like structures in human uveitis. Exp Eye Res. 2020;191:107901 pubmed publisher
  24. Griss J, Bauer W, Wagner C, Simon M, Chen M, Grabmeier Pfistershammer K, et al. B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma. Nat Commun. 2019;10:4186 pubmed publisher
  25. Menon V, Thomas R, Elgueta C, Horl M, Osborn T, Hallett P, et al. Comprehensive Cell Surface Antigen Analysis Identifies Transferrin Receptor Protein-1 (CD71) as a Negative Selection Marker for Human Neuronal Cells. Stem Cells. 2019;37:1293-1306 pubmed publisher
  26. van de Vlekkert D, Demmers J, Nguyen X, Campos Y, Machado E, Annunziata I, et al. Excessive exosome release is the pathogenic pathway linking a lysosomal deficiency to generalized fibrosis. Sci Adv. 2019;5:eaav3270 pubmed publisher
  27. Schirmer L, Velmeshev D, Holmqvist S, Kaufmann M, Werneburg S, Jung D, et al. Neuronal vulnerability and multilineage diversity in multiple sclerosis. Nature. 2019;573:75-82 pubmed publisher
  28. Yao W, Rose J, Wang W, Seth S, Jiang H, Taguchi A, et al. Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer. Nature. 2019;: pubmed publisher
  29. Kriegsmann K, Baertsch M, Awwad M, Merz M, Hose D, Seckinger A, et al. Cereblon-binding proteins expression levels correlate with hyperdiploidy in newly diagnosed multiple myeloma patients. Blood Cancer J. 2019;9:13 pubmed publisher
  30. Bouafia A, Lofek S, Bruneau J, Chentout L, Lamrini H, Trinquand A, et al. Loss of ARHGEF1 causes a human primary antibody deficiency. J Clin Invest. 2019;129:1047-1060 pubmed publisher
  31. Liu S, Wang F, Liu G. Knockdown of pleiotrophin increases the risk of preeclampsia following vitrified-thawed embryo transfer. Int J Oncol. 2018;53:1847-1856 pubmed publisher
  32. Burton A, Pallett L, McCoy L, Suveizdyte K, Amin O, Swadling L, et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Invest. 2018;128:4588-4603 pubmed publisher
  33. Gao P, He C, Zhang C, Li B, Guo Y, Zhao W, et al. Preventive effect on endothelial surface layer damage of Fusu agent in LPS-induced acute lung injury in rats. Mol Cell Biochem. 2019;450:113-123 pubmed publisher
  34. Liu J, Huang X, Hao S, Wang Y, Liu M, Xu J, et al. Peli1 negatively regulates noncanonical NF-κB signaling to restrain systemic lupus erythematosus. Nat Commun. 2018;9:1136 pubmed publisher
  35. Lee L, Draper B, Chaplin N, Philip B, Chin M, Galas Filipowicz D, et al. An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma. Blood. 2018;131:746-758 pubmed publisher
  36. Marchesini M, Ogoti Y, Fiorini E, Aktaş Samur A, Nezi L, D Anca M, et al. ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma. Cancer Cell. 2017;32:88-100.e6 pubmed publisher
  37. Tanaka A, Tumkosit U, Nakamura S, Motooka D, Kishishita N, Priengprom T, et al. Genome-Wide Screening Uncovers the Significance of N-Sulfation of Heparan Sulfate as a Host Cell Factor for Chikungunya Virus Infection. J Virol. 2017;91: pubmed publisher
  38. Rao D, Gurish M, Marshall J, Slowikowski K, Fonseka C, Liu Y, et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017;542:110-114 pubmed publisher
  39. Liddelow S, Guttenplan K, Clarke L, Bennett F, Bohlen C, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481-487 pubmed publisher
  40. Bolzoni M, Ronchetti D, Storti P, Donofrio G, Marchica V, Costa F, et al. IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts. Haematologica. 2017;102:773-784 pubmed publisher
  41. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  42. Grigorov B, Reungoat E, Gentil dit Maurin A, Varbanov M, Blaising J, Michelet M, et al. Hepatitis C virus infection propagates through interactions between Syndecan-1 and CD81 and impacts the hepatocyte glycocalyx. Cell Microbiol. 2017;19: pubmed publisher
  43. Sherbenou D, Aftab B, Su Y, Behrens C, Wiita A, Logan A, et al. Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells. J Clin Invest. 2016;126:4640-4653 pubmed publisher
  44. Wang J, Qiao L, Hou Z, Luo G. TIM-1 Promotes Hepatitis C Virus Cell Attachment and Infection. J Virol. 2017;91: pubmed publisher
  45. Alonso S, Hernandez D, Chang Y, Gocke C, McCray M, Varadhan R, et al. Hedgehog and retinoid signaling alters multiple myeloma microenvironment and generates bortezomib resistance. J Clin Invest. 2016;126:4460-4468 pubmed publisher
  46. Ayres Pereira M, Mandel Clausen T, Pehrson C, Mao Y, Resende M, Daugaard M, et al. Placental Sequestration of Plasmodium falciparum Malaria Parasites Is Mediated by the Interaction Between VAR2CSA and Chondroitin Sulfate A on Syndecan-1. PLoS Pathog. 2016;12:e1005831 pubmed publisher
  47. Zeng Y, Yao X, Chen L, Yan Z, Liu J, Zhang Y, et al. Sphingosine-1-phosphate induced epithelial-mesenchymal transition of hepatocellular carcinoma via an MMP-7/ syndecan-1/TGF-β autocrine loop. Oncotarget. 2016;7:63324-63337 pubmed publisher
  48. Ashizawa T, Iizuka A, Nonomura C, Kondou R, Maeda C, Miyata H, et al. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse. Clin Cancer Res. 2017;23:149-158 pubmed publisher
  49. Xue C, Yu D, Gherardi S, Koach J, Milazzo G, Gamble L, et al. MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4. Oncotarget. 2016;7:54937-54951 pubmed publisher
  50. Coccaro N, Tota G, Anelli L, Zagaria A, Casieri P, Cellamare A, et al. MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32). Oncol Lett. 2016;12:1460-1464 pubmed
  51. Piepenbrink M, Samuel M, Zheng B, Carter B, Fucile C, Bunce C, et al. Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users. PLoS ONE. 2016;11:e0158641 pubmed publisher
  52. Pagnotti G, Chan M, Adler B, Shroyer K, Rubin J, Bain S, et al. Low intensity vibration mitigates tumor progression and protects bone quantity and quality in a murine model of myeloma. Bone. 2016;90:69-79 pubmed publisher
  53. Neumann B, Shi T, Gan L, Klippert A, Daskalaki M, Stolte Leeb N, et al. Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus). J Med Primatol. 2016;45:139-46 pubmed publisher
  54. Yu C, Liu Y, Chan J, Tong J, Li Z, Shi M, et al. Identification of human plasma cells with a lamprey monoclonal antibody. JCI Insight. 2016;1: pubmed
  55. Tuşaliu M, Zainea V, Mogoantă C, Dragu A, GoanŢă C, Niţescu M, et al. Diagnostic and therapeutic aspects in malignant sinonasal lymphoma. Rom J Morphol Embryol. 2016;57:233-6 pubmed
  56. Brown P, Gascoyne D, Lyne L, Spearman H, Felce S, McFadden N, et al. N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells. Haematologica. 2016;101:861-71 pubmed publisher
  57. Gibson S, Picarsic J, Swerdlow S, Pantanowitz L. Role of Epstein-Barr virus status and immunophenotypic studies in the evaluation of exfoliative cytology specimens from patients with post-transplant lymphoproliferative disorders. Cancer Cytopathol. 2016;124:425-35 pubmed publisher
  58. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  59. Bengtsson E, Lindblom K, Tillgren V, Aspberg A. The leucine-rich repeat protein PRELP binds fibroblast cell-surface proteoglycans and enhances focal adhesion formation. Biochem J. 2016;473:1153-64 pubmed publisher
  60. Llibre A, López Macías C, Marafioti T, Mehta H, Partridge A, Kanzig C, et al. LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation. J Immunol. 2016;196:2085-94 pubmed publisher
  61. Allaire J, Roy S, Ouellet C, Lemieux Ã, Jones C, Paquet M, et al. Bmp signaling in colonic mesenchyme regulates stromal microenvironment and protects from polyposis initiation. Int J Cancer. 2016;138:2700-12 pubmed publisher
  62. Hosseini A, Hirota J, Hackett T, McNagny K, Wilson S, Carlsten C. Morphometric analysis of inflammation in bronchial biopsies following exposure to inhaled diesel exhaust and allergen challenge in atopic subjects. Part Fibre Toxicol. 2016;13:2 pubmed publisher
  63. Martínez Martínez M, Mosqueda Taylor A, Delgado Azañero W, Rumayor Piña A, de Almeida O. Primary intraosseous squamous cell carcinoma arising in an odontogenic keratocyst previously treated with marsupialization: case report and immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121:e87-95 pubmed publisher
  64. Hasby E. Mammary serine protease inhibitor and CD138 immunohistochemical expression in ovarian serous and clear cell carcinomas. Tumour Biol. 2016;37:4889-900 pubmed publisher
  65. Gopal S, Søgaard P, Multhaupt H, Pataki C, Okina E, Xian X, et al. Transmembrane proteoglycans control stretch-activated channels to set cytosolic calcium levels. J Cell Biol. 2015;210:1199-211 pubmed publisher
  66. O Carroll S, Kho D, Wiltshire R, Nelson V, Rotimi O, Johnson R, et al. Pro-inflammatory TNFα and IL-1β differentially regulate the inflammatory phenotype of brain microvascular endothelial cells. J Neuroinflammation. 2015;12:131 pubmed publisher
  67. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed publisher
  68. Wang J, Ma L, Tang X, Zhang X, Qiao Y, Shi Y, et al. Doxorubicin induces apoptosis by targeting Madcam1 and AKT and inhibiting protein translation initiation in hepatocellular carcinoma cells. Oncotarget. 2015;6:24075-91 pubmed
  69. Berg A, Soma L, Clark B, Swerdlow S, Roth C. Evaluating breast lymphoplasmacytic infiltrates: a multiparameter immunohistochemical study, including assessment of IgG4. Hum Pathol. 2015;46:1162-70 pubmed publisher
  70. Coulson Thomas V, Chang S, Yeh L, Coulson Thomas Y, Yamaguchi Y, Esko J, et al. Loss of corneal epithelial heparan sulfate leads to corneal degeneration and impaired wound healing. Invest Ophthalmol Vis Sci. 2015;56:3004-14 pubmed publisher
  71. Zhu D, Wang Z, Zhao J, Calimeri T, Meng J, Hideshima T, et al. The Cyclophilin A-CD147 complex promotes the proliferation and homing of multiple myeloma cells. Nat Med. 2015;21:572-80 pubmed publisher
  72. Pasqualon T, Pruessmeyer J, Weidenfeld S, Babendreyer A, Groth E, Schumacher J, et al. A transmembrane C-terminal fragment of syndecan-1 is generated by the metalloproteinase ADAM17 and promotes lung epithelial tumor cell migration and lung metastasis formation. Cell Mol Life Sci. 2015;72:3783-801 pubmed publisher
  73. Fromm J, Tagliente D, Shaver A, Neppalli V, Craig F. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry B Clin Cytom. 2015;88:413-24 pubmed publisher
  74. Nakada S, Minato H, Takegami T, Kurose N, Ikeda H, Kobayashi M, et al. NAB2-STAT6 fusion gene analysis in two cases of meningeal solitary fibrous tumor/hemangiopericytoma with late distant metastases. Brain Tumor Pathol. 2015;32:268-74 pubmed publisher
  75. Desantis A, Bruno T, Catena V, De Nicola F, Goeman F, Iezzi S, et al. Che-1-induced inhibition of mTOR pathway enables stress-induced autophagy. EMBO J. 2015;34:1214-30 pubmed publisher
  76. Overdijk M, Verploegen S, Bögels M, van Egmond M, Lammerts van Bueren J, Mutis T, et al. Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma. MAbs. 2015;7:311-21 pubmed publisher
  77. Lewis M, Vyse S, Shields A, Boeltz S, Gordon P, Spector T, et al. UBE2L3 polymorphism amplifies NF-κB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases. Am J Hum Genet. 2015;96:221-34 pubmed publisher
  78. García Carmona Y, Cols M, Ting A, Radigan L, Yuk F, Zhang L, et al. Differential induction of plasma cells by isoforms of human TACI. Blood. 2015;125:1749-58 pubmed publisher
  79. Lim H, Multhaupt H, Couchman J. Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells. Mol Cancer. 2015;14:15 pubmed publisher
  80. de Masson A, Bouaziz J, Le Buanec H, Robin M, O Meara A, Parquet N, et al. CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease. Blood. 2015;125:1830-9 pubmed publisher
  81. Zhang G, Gomes Giacoia E, Dai Y, Lawton A, Miyake M, Furuya H, et al. Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature. Diagn Pathol. 2014;9:200 pubmed publisher
  82. Jabbour M, Issa G, Charafeddine K, Simaan Y, Karam M, Khalifeh H, et al. The immune microenvironment in cutaneous leishmaniasis. J Eur Acad Dermatol Venereol. 2015;29:1170-9 pubmed publisher
  83. Lim G, Tan P, Jara Lazaro A, Thike A, Sim W, Yap V, et al. Syndecan-1 is a potential biomarker for triple-positive breast carcinomas in Asian women with correlation to survival. Singapore Med J. 2014;55:468-72 pubmed
  84. Mansoor A, Akhter A, Pournazari P, Mahe E, Shariff S, Farooq F, et al. Protein Expression for Novel Prognostic Markers (Cyclins D1, D2, D3, B1, B2, ITGβ7, FGFR3, PAX5) Correlate With Previously Reported Gene Expression Profile Patterns in Plasma Cell Myeloma. Appl Immunohistochem Mol Morphol. 2015;23:327-33 pubmed publisher
  85. Salvestrini C, Lucas M, Lionetti P, Torrente F, James S, Phillips A, et al. Matrix expansion and syncytial aggregation of syndecan-1+ cells underpin villous atrophy in coeliac disease. PLoS ONE. 2014;9:e106005 pubmed publisher
  86. Coulson Thomas V, Gesteira T, Esko J, KAO W. Heparan sulfate regulates hair follicle and sebaceous gland morphogenesis and homeostasis. J Biol Chem. 2014;289:25211-26 pubmed publisher
  87. Gomez A, Willcox N, Vrolix K, Hummel J, Nogales Gadea G, Saxena A, et al. Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patients. J Immunol. 2014;193:1055-1063 pubmed publisher
  88. Steinsbø Ø, Henry Dunand C, Huang M, Mesin L, Salgado Ferrer M, Lundin K, et al. Restricted VH/VL usage and limited mutations in gluten-specific IgA of coeliac disease lesion plasma cells. Nat Commun. 2014;5:4041 pubmed publisher
  89. Itoua Maïga R, Lemieux J, Roy A, Simard C, Néron S. Flow cytometry assessment of in vitro generated CD138+ human plasma cells. Biomed Res Int. 2014;2014:536482 pubmed publisher
  90. Huang S, Lin C, Lin H, Yao M, Tang J, Wu S, et al. Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma. Ann Hematol. 2014;93:1371-80 pubmed publisher
  91. Shikhagaie M, Andersson C, Mori M, Kortekaas Krohn I, Bergqvist A, Dahl R, et al. Mapping of TLR5 and TLR7 in central and distal human airways and identification of reduced TLR expression in severe asthma. Clin Exp Allergy. 2014;44:184-96 pubmed publisher
  92. Frigyesi I, Adolfsson J, Ali M, Christophersen M, Johnsson E, Turesson I, et al. Robust isolation of malignant plasma cells in multiple myeloma. Blood. 2014;123:1336-40 pubmed publisher
  93. Nguyen T, Grizzle W, Zhang K, Hameed O, Siegal G, Wei S. Syndecan-1 overexpression is associated with nonluminal subtypes and poor prognosis in advanced breast cancer. Am J Clin Pathol. 2013;140:468-74 pubmed publisher
  94. Turkki P, Makkonen K, Huttunen M, Laakkonen J, Yla Herttuala S, Airenne K, et al. Cell susceptibility to baculovirus transduction and echovirus infection is modified by protein kinase C phosphorylation and vimentin organization. J Virol. 2013;87:9822-35 pubmed publisher
  95. Young E, Berthier E, Beebe D. Assessment of enhanced autofluorescence and impact on cell microscopy for microfabricated thermoplastic devices. Anal Chem. 2013;85:44-9 pubmed publisher
  96. Petrilli G, Lorenzi L, Paracchini R, Ubiali A, Schumacher R, Cabassa P, et al. Epstein-Barr virus-associated adrenal smooth muscle tumors and disseminated diffuse large B-cell lymphoma in a child with common variable immunodeficiency: a case report and review of the literature. Int J Surg Pathol. 2014;22:712-21 pubmed publisher
  97. Sahlin L, Stjernholm Vladic Y, Roos N, Masironi B, Ekman Ordeberg G. Impaired leukocyte influx in cervix of postterm women not responding to prostaglandin priming. Reprod Biol Endocrinol. 2008;6:36 pubmed publisher